Florkowski CM - Search Results

1

Bone mineral density is reduced in female but not male subjects with Addison's disease.

Florkowski CM, Holmes SJ, Elliot JR, Donald RA, Espiner EA. Florkowski CM, et al. N Z Med J. 1994 Feb 23;107(972):52-3. N Z Med J. 1994. PMID: 8115069

2

Acutely raised corticotropin levels in Addison's disease are not associated with increased plasma arginine vasopressin and corticotropin-releasing factor concentrations in peripheral plasma.

Wittert GA, Livesey JH, Florkowski C, Or HK, Donald RA, Espiner EA. Wittert GA, et al. J Clin Endocrinol Metab. 1993 Jan;76(1):192-6. doi: 10.1210/jcem.76.1.8380605. J Clin Endocrinol Metab. 1993. PMID: 8380605

3

Bone mineral density in patients receiving suppressive doses of thyroxine for thyroid carcinoma.

Florkowski CM, Brownlie BE, Elliot JR, Ayling EM, Turner JG. Florkowski CM, et al. N Z Med J. 1993 Oct 27;106(966):443-4. N Z Med J. 1993. PMID: 8233173

4

The case for growth hormone replacement in adult hypopituitarism.

Florkowski CM, Holdaway IM, Manning PJ, Donald RA. Florkowski CM, et al. N Z Med J. 1996 Sep 27;109(1030):349-51. N Z Med J. 1996. PMID: 8890858 Review. No abstract available.

5

A population-based study of bone mineral density in women with longstanding type 1 (insulin dependent) diabetes.

Lunt H, Florkowski CM, Cundy T, Kendall D, Brown LJ, Elliot JR, Wells JE, Turner JG. Lunt H, et al. Among authors: florkowski cm. Diabetes Res Clin Pract. 1998 Apr;40(1):31-8. doi: 10.1016/s0168-8227(98)00012-6. Diabetes Res Clin Pract. 1998. PMID: 9699088

6

Glucocorticoid responsive ACTH secreting bronchial carcinoid tumours contain high concentrations of glucocorticoid receptors.

Florkowski CM, Wittert GA, Lewis JG, Donald RA, Espiner EA. Florkowski CM, et al. Clin Endocrinol (Oxf). 1994 Feb;40(2):269-74. doi: 10.1111/j.1365-2265.1994.tb02479.x. Clin Endocrinol (Oxf). 1994. PMID: 8137528

7

Metyrapone induced increase in plasma corticotropin is not associated with changes in peripheral venous arginine vasopressin or corticotropin releasing factor.

Holmes SJ, Florkowski CM, Evans MJ, Ellis MJ, Livesey JH, Donald RA, Espiner EA. Holmes SJ, et al. Among authors: florkowski cm. J Endocrinol Invest. 1993 Nov;16(10):787-92. doi: 10.1007/BF03348928. J Endocrinol Invest. 1993. PMID: 8144852 Clinical Trial.

8

Plasma cortisol, PRL, ACTH, AVP and corticotrophin releasing hormone responses to direct current cardioversion and electroconvulsive therapy.

Florkowski CM, Crozier IG, Nightingale S, Evans MJ, Ellis MJ, Joyce P, Donald RA. Florkowski CM, et al. Clin Endocrinol (Oxf). 1996 Feb;44(2):163-8. doi: 10.1046/j.1365-2265.1996.642464.x. Clin Endocrinol (Oxf). 1996. PMID: 8849570

9

Low-dose growth hormone replacement lowers plasma leptin and fat stores without affecting body mass index in adults with growth hormone deficiency.

Florkowski CM, Collier GR, Zimmet PZ, Livesey JH, Espiner EA, Donald RA. Florkowski CM, et al. Clin Endocrinol (Oxf). 1996 Dec;45(6):769-73. doi: 10.1046/j.1365-2265.1996.830895.x. Clin Endocrinol (Oxf). 1996. PMID: 9039344 Clinical Trial.

10

Growth hormone replacement does not improve psychological well-being in adult hypopituitarism: a randomized crossover trial.

Florkowski CM, Stevens I, Joyce P, Espiner EA, Donald RA. Florkowski CM, et al. Psychoneuroendocrinology. 1998 Jan;23(1):57-63. doi: 10.1016/s0306-4530(97)00093-0. Psychoneuroendocrinology. 1998. PMID: 9618752 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters